Cellino Biotech rallies $80m Series A

Cellino Biotech Inc., an autonomous cell therapy manufacturing company, has raised $80 million in Series A financing.

25 January 2022•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles